HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 103 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,729,661 | -4.6% | 3,684,152 | +2.5% | 0.00% | 0.0% |
| Q2 2023 | $126,538,208 | +9.6% | 3,595,857 | +1.7% | 0.00% | 0.0% |
| Q1 2023 | $115,427,056 | -35.6% | 3,535,285 | +8.6% | 0.00% | -40.0% |
| Q4 2022 | $179,330,719 | +34.8% | 3,254,641 | +8.4% | 0.01% | +25.0% |
| Q3 2022 | $133,023,000 | -8.0% | 3,003,456 | +1.3% | 0.00% | 0.0% |
| Q2 2022 | $144,579,000 | +10.0% | 2,964,498 | +9.7% | 0.00% | +33.3% |
| Q1 2022 | $131,478,000 | +16.0% | 2,702,513 | +1.6% | 0.00% | 0.0% |
| Q4 2021 | $113,383,000 | -4.6% | 2,659,085 | -14.2% | 0.00% | 0.0% |
| Q3 2021 | $118,820,000 | +262.2% | 3,099,941 | +166.8% | 0.00% | +200.0% |
| Q2 2021 | $32,801,000 | +22.4% | 1,161,875 | +43.3% | 0.00% | 0.0% |
| Q1 2021 | $26,794,000 | +340.7% | 810,940 | +382.2% | 0.00% | – |
| Q4 2020 | $6,080,000 | – | 168,182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |